Excell Research, Inc. has created this privacy statement to demonstrate our firm commitment to privacy. The following discloses our information gathering and dissemination practices for this website: www.excellresearch.com. If at any time you find this privacy policy unacceptable, you must immediately leave this website.
We respect your privacy. Any information we collect from you, including your email address, will simply be used to send you the information you have requested. We will not give or sell your personal information to any unaffiliated third party. If you give us your email and permission to send more information, you may opt out of receiving any additional email messages at any time, by unsubscribing from our email list.
Information Gathering
We use your IP address to help diagnose problems with our server and to administer our website by (1) identifying which parts of our site are most heavily used (2) to tailor site content to user needs and (3) to generate aggregate statistical reports. We do not link IP addresses to anything personally identifiable. This means that user sessions will be tracked, but the users will remain anonymous.
You need not provide Excell Research, Inc with personally identifying information (e.g., name, telephone number, email address, city and/or state of residence) as a condition of using our site. However, your failure to provide certain personally identifying information when asked will prevent certain features of the website from functioning or will prevent Excell Research, Inc. from effectively responding to certain of your requests. The website will collect only that personally identifying information that you affirmatively provide in response to a direct request.
We use a tool called “Google Analytics” to collect information about use of this site. Google Analytics collects information such as how often users visit this site, what pages they visit when they do so, and what other sites they used prior to coming to this site. We use the information we get from Google Analytics only to improve our website. Google Analytics collects only the IP address assigned to your browser on the date of your visit, instead of your name or other identifying information. We do not combine the information collected through the use of Google Analytics with any personally identifiable information. Although Google Analytics plants a “cookie” on your web browser to identify you as a unique user the cookie cannot be used by anyone but Google. Google’s ability to use and share information collected by Google Analytics about your visits to this site is restricted by the Google Analytics Terms of Use and the Google Privacy Policy. You can prevent Google Analytics from recognizing your return visits to this site by disabling cookies on your browser. Please refer to your browser settings for additional information on disabling cookies or visit Google Analytics’ currently available opt-outs for the web.
Copyright
Unless otherwise noted, all contents of Excell Research, Inc.’s website are copyright Excell Research, Inc. All rights reserved.
Security
Excell Research, Inc. has implemented and maintains reasonable security procedures and practices to protect against the unauthorized access, use, modification, destruction or disclosure of your personally identifying information.
Equal Opportunity / Affirmative Action
Excell Research, Inc. is committed to a policy of equal treatment and opportunity in every aspect of its relations with its faculty, students, and staff members, without regard to age, citizenship status, color, disability, marital or parental status, national origin, race, religion, sex, or sexual orientation.
Contacting Excell Research, Inc.
If you have any questions about this privacy statement, the practices of this site, or your dealings with this website, you can contact Excell Research, Inc.:
Purpose:
List clear guidelines, which must be followed to Assessing COVID-19 Status, Symptoms and/or Risk Factors
All procedures will adhere strictly to GCP guidelines. Guidelines are subject to change based on any new updates from the CDC, WHO, and/or FDA.
Procedure(s):
To ensure all subjects have been properly assessed for COVID-19, symptoms, and/or risk factors, the following procedures include but are not limited to:
a) Site staff will contact the subject the business day prior to their appointment to confirm the following:
i) Have they experienced any symptoms of COVID-19 (i.e. Fever, Cough, Shortness of Breath, Chills, Repeated shaking with Chills, Muscle Pain, Headache, Sore Throat, loss of taste or smell, etc) within the last two weeks?
ii) Have they been exposed to anyone who has exhibited symptoms of COVID-19 (i.e. Fever, Cough, Shortness of Breath, Chills, Repeated shaking with Chills, Muscle Pain, Headache, Sore Throat, loss of taste or smell, etc) within the past two weeks?
If the subject responds “No” to both of those questions, the subject’s appointment is confirmed for a Face-to-Face visit.
b) Site staff will instruct the subject prior to their appointment that they are required to have a mask (if unvaccinated) or facial covering while completing a COVID-19 questionnaire and temperature check. Site staff (Investigators, Raters, Study Coordinators, Lab Technicians, Front Office staff, Research Assistants, Onsite Monitors/CRA’s, etc) will be required to wear a mask or facial covering while meeting with a patient at the patients request.
i) If the subject presents with a fever, the subject is immediately asked to leave, and the adverse event is documented appropriately per the protocol. The exam room is disinfected using Cavi Wipes and Lysol Spray, pillowcases and exam table paper is removed and bagged, all equipment in the room is sanitized and the room is then decommissioned until the next business day.
ii) If the subject does not present with a fever, all protocol procedures (including but not limited to Informed Consent, Vital Signs, ECG’s, Blood Draws, Patient Reported Outcomes, Rating Assessments, IP accountability and administration, etc) are completed in the exam room. Social distancing is maintained in the exam room between the subject and employee. The patient may request staff members to wear a mask if needed.
1) If a protocol requires the use of a tablet, the tablet is wiped down after every user. Subjects and/or Employees are required to wash hands for at least 20 seconds with soap and water prior to and after using the tablet.
iii) Exam rooms are cleaned with Cavi Wipes and Lysol Spray between each subject. New pillowcases are applied on each pillow and new table paper is applied to the exam table. All ECG cords/machines are wiped down, blood pressure cuff is sanitized with Lysol, thermometers are wiped down, etc.
c) Staff and subjects are advised to maintain social distance while walking in the halls or in the lobby. To ensure proper distance between subjects while in the lobby, two thirds of the chairs have been removed. The subject will remain in the exam room but if for any reason they are required to wait in the lobby, subjects are to remain seated in the same seat until asked to move to the exam room.
i) After use of any chairs in the lobby, the furniture is sanitized with Lysol Spray and Cavi Wipes.
ii) The site limits the quantity of subjects waiting in the lobby to no more than four subjects at any given time.
d) Frequent proper hand washing is highly encouraged to all site staff and subjects while onsite. Hand Sanitation stations have been placed throughout the entire office.
Updated: March 31, 2022.